drugset / Trial / NCT01587963

High Dose Vitamin C in the Critically Ill Patient

NCT01587963

Phase 2 Terminated 11 enrolled Rutgers, The State University of New Jersey
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine the effectiveness of high doses of Vitamin C in critically ill patients.

Timeline

Start
2013-02
Primary completion
2014-02
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vitamin C Other / unclassified 66 mg/kg Intravenous

Indications

No indication recorded.